MTUS1 and cancer: Our data support a mechanism by which ATIP3 silencing favors paclitaxel accumulation on microtubules in interphase cancer cells by increasing the dynamic behavior of growing microtubule plus ends, thereby sensitizing cells to the anti-migratory effects of the drug.